- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02973373
MRI of the Chest Under High Frequency Ventilation
March 2, 2020 updated by: Beigelman-Aubry Catherine, University of Lausanne Hospitals
The purpose of the study is to evaluate the benefit on image quality of MRI of the chest performed under high frequency non-invasive ventilation.
This technique indeed allows to generate an apnea duration of several minutes with acquisitions performed at full inspiration.
This study will be applied on healthy subjects.
Study Overview
Status
Completed
Detailed Description
High frequency ventilation (HF-V) has been applied by using a non-invasive interface allowing to obtain a prolonged apnea in awaken subjects.
Such an application should be of interest for MRI taking into account its susceptibility to motion of the chest and the imperfect techniques of respiratory gating that are usually performed at end expiration.
The purpose of this study is to assess the benefit on image quality of different sequences performed with and without the device in healthy subjects.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lausanne, Switzerland, 1011
- University Hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy subjets : normal respiratory function and no known lung disease
- Age >=18y
Exclusion Criteria:
• Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: MRI with HF-NIV
Intervention: Acquisition of MRI with High-Frequency non-invasive ventilation (HF-NIV)
|
MRI performed under high-frequency non-invasive ventilation
|
|
ACTIVE_COMPARATOR: MRI without HF-NIV
Intervention: MRI without High-Frequency non-invasive ventilation (HF-NIV)
|
MRI performed without High-frequency non-invasive ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Image quality assessment (soapbubble, maximum of first derivative, signal to noise, contrast to noise)
Time Frame: within 2 weeks after MRI acquisition
|
Image quality and artefacts will be evaluated and compared without and with the device.
Sharpness of the interfaces between vessels and lung will be evaluated with the Soapbubble software (Etienne et al., Magn Reson Med.
2002 Oct;48(4):658-66).
The interface between diaphragm and lung will be evaluated with the maximum of the first derivative (Tibiletti et al., Magn Reson Med.
2016 Mar;75(3):1324-32).
Signal to noise and contrast to noise will be measured within regions of interest in the image.
|
within 2 weeks after MRI acquisition
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart and coronary arteries evaluation (soapbubble, signal to noise, contrast to noise)
Time Frame: within 2 weeks after MRI acquisition
|
The potential benefit on the exploration of the heart and coronary arteries will be assessed.
Sharpness of the coronary arteries with respect to the neighbouring tissue will be evaluated with the Soapbubble software (Etienne et al., Magn Reson Med.
2002 Oct;48(4):658-66).
Signal to noise and contrast to noise will be measured within regions of interest in the image.
|
within 2 weeks after MRI acquisition
|
|
Synchronization of the acquisition
Time Frame: during the MRI examination
|
The possibility of synchronizing the MRI acquisition with the ventilation system will be explored with the aim to eliminate residual diaphragmatic motion and evaluate the potential additional benefit in terms of image quality and artefacts will be evaluated.
|
during the MRI examination
|
|
Subjective tolerance (questionnaire)
Time Frame: at the end of the MRI examination
|
Subjective tolerance of MRI examination under HF-NIV (questionnaire).
Participants will fill the questionnaire right after the examination end.
|
at the end of the MRI examination
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Catherine I Beigelman-Aubry, MD, University Hospitals Lausanne Switzerland
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 1, 2016
Primary Completion (ACTUAL)
July 1, 2017
Study Completion (ACTUAL)
July 1, 2017
Study Registration Dates
First Submitted
November 17, 2016
First Submitted That Met QC Criteria
November 21, 2016
First Posted (ESTIMATE)
November 25, 2016
Study Record Updates
Last Update Posted (ACTUAL)
March 5, 2020
Last Update Submitted That Met QC Criteria
March 2, 2020
Last Verified
March 1, 2020
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
AbbVieRecruiting
-
AbbVieNot yet recruiting
-
Advenchen Laboratories Nanjing Ltd.Not yet recruitingHealthy VolunteerChina
-
Hinge BioRecruiting
-
HK inno.N CorporationNot yet recruitingHealthy VolunteerSouth Korea
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Mirador Therapeutics, Inc.Recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Protagonist Therapeutics, Inc.RecruitingHealthy VolunteerAustralia
Clinical Trials on MRI with High-frequency non-invasive ventilation
-
Muhammad Aamir LatifCompletedRespiratory Distress SyndromePakistan
-
Centre Hospitalier Universitaire VaudoisUnknownLung Diseases | Healthy Volunteer | Non-invasive Ventilation | High-frequency VentilationSwitzerland
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOPD | Non-invasive VentilationChina
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingHealthy Subjects | Non-invasive VentilationChina
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOPD Exacerbation | Non-invasive Ventilation
-
Indus Hospital and Health NetworkWithdrawnRespiratory Distress Syndrome in Premature InfantPakistan
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOVID-19 Pneumonia | Non-invasive Ventilation
-
University Hospital, MontpellierCompletedIntubation IntraesophagealFrance
-
University Hospital, GrenobleTerminatedRespiratory Acidosis in ICU PatientsFrance
-
Fisher and Paykel HealthcareNot yet recruitingRespiratory Failure Requiring Non Invasive Ventilation